{"url_path":"/sec/vani/8-k/2026-06-30/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-001109-index.html","accession_number":"0001753926-26-001109","cik":"0001266806","ticker":"VANI","issuer_name":"Vivani Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-001109-index.html","primary_entity_key":"0001266806","primary_entity_name":"Vivani Medical, Inc."},"word_count":111,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n \n\n(d) Exhibits.\n\n       \n\nExhibit No.\n\nDescription\n\n[10.1#](ex101_1.htm)\n\n \n\n[Vivani Medical, Inc. Amended and Restated 2022 Omnibus Incentive Plan, and form award agreements thereunder.](ex101_1.htm)\n\n[99.1](ex991_2.htm)\n\n \n\n[Press release issued by Vivani Medical, Inc. on June 25, 2026.](ex991_2.htm)\n\n \n\n \n\n \n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document). \n\n # Indicates a management contract or any compensatory plan, contract or arrangement.\n\n \n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nVIVANI MEDICAL, INC.\n\n \n\n \n\n \n\nDate: June 30, 2026\n\nBy:\n\n/s/ Donald Dwyer\n\n \n\nName:\n\nDonald Dwyer\n\n \n\nTitle:\n\nChief Business Officer"}